Annals of Internal Medicine: Clinical and Epidemiologic Features of Primary HIV Infection

Annals of Internal Medicine

Volumn 125, Issue 4, 1996, Pages 257-264

  Schacker, Timothy ^a   Collier, Ann C ^a,b   Hughes, James ^a   Shea, Theresa ^a,c   Corey, Lawrence ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b AIDS Clinical Trials Unit   (United States)

^c Primary Infection Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS RNA;

ADULT; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; FEMALE; GENETICS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; TIME; UNITED STATES;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SEROPOSITIVITY; HOMOSEXUALITY; HUMANS; MALE; POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; TIME FACTORS; UNITED STATES; WASHINGTON;

EID: 0030586445     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-4-199608150-00001     Document Type: Article

References (32)

1. Tindall B, Barker S, Donovan B, Barnes T, Roberts J, Kronenberg C, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med. 1988;148:945-9.
2. Dewar RL, Highbarger HC, Sarmiento MD, Todd JA, Vasudevachari MB, Davey RT Jr, et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis. 1994;170:1172-9.
3. Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong SJ, Stempien M, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;8:446-54.
4. Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 1989;321:1626-31.
5. Collier AC, Bozzette S, Coombs RW, Causey DM, Schoenfeld DA, Spector SA, et al. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med. 1990;323:1015-21.
6. Winkelstein W Jr, Samuel M, Padian NS, Wiley JA, Lang W, Anderson RE, et al. The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. Am J Public Health. 1987;77:685-9.
7. Winkelstein W Jr, Wiley JA, Padian NS, Samuel M, Shiboski S, Ascher MS, et al. The San Francisco Men's Health Study: continued decline in HIV seroconversion rates among homosexual/bisexual men. Am J Public Health. 1988;78:1472-4.
8. Stevens CE, Taylor PE, Zang EA, Morrison JM, Harley EJ, Rodriguez de Cordoba S, et al. Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City JAMA. 1986;255:2167-72.
9. van Griensven GJ, de Vroome EM, Goudsmit J, Coutinho RA. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ. 1989;298:218-21.
10. Schwarcz SK, Kellogg TA, Kohn RP, Katz MH, Lemp GF, Golan GA. Temporal trends in human immunodeficiency virus seroprevalence and sexual behavior at the San Francisco municipal sexually transmitted disease clinic, 1989-1992. Am J Epidemiol. 1995;142:314-22.
11. Maayan S, Soskolne V, Engelhard D, Moses A, Rahav G, Raveh D, et al. Sexual behavior of homosexual and bisexual man attending an HIV testing clinic in Jerusalem 1986/7-1990. Isr J Psychiatry Rel Sci. 1993;30:150-4.
12. Kingsley LA, Detels R, Kaslow R, Polk BF, Rinaldo CR Jr, Chmiel J, et al. Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet. 1987;1:345-9.
13. van Griensven GJ, Tielman RA, Goudsmit J, van der Noordaa J, de Wolf F, de Vroome EM, et al. Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. Am J Epidemiol 1987;125:1048-57.
14. Lifson AR, O'Malley PM, Hessol NA, Buchbinder SP, Cannon L, Rutherford GW. HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. Am J Public Health, 1990;80:1509-11.
15. Keet IP, Albrecht van Lent N, Sandfort TG, Coutinho RA, van Griensven GJ. Urogenital sex and the transmission of HIV among homosexual men. AIDS. 1992;6:223-6
16. Rozenbaum W, Gharakhanian S, Cardon B, Duval E, Coulaud JP. HIV transmission by oral sex [Letter]. Lancet. 1988;1:1395
17. Murray AB, Greenhouse PR, Nelson WL, Norman JE, Jeffries DJ, Anderson J. Coincident acquisition of Neisseria gonorrhoeae and HIV from fellatio [Letter]. Lancet. 1991;338:830.
18. Lane HC, Holmberg SD, Jaffe HW. HIV seroconversion and oral intercourse [Letter]. Am J Public Health. 1991;81:658.
19. Schlechter MT, Craib KJ, Willoughby B, Douglas B, McLeod WA, Maynard M, et al. Patterns of sexual behavior and condom use in a cohort of homosexual men. Am J Public Health. 1988;78:1535-8.
20. van Griensven GJ, de Vroome EM, Tielman RA, Goudsmit J, van der Noordaa J, de Wolf F, et al. Impact of HIV antibody testing on changes in sexual behavior among homosexual men in The Netherlands. Am J Public Health. 1988;78:1575-7.
21. Rhame FS, Maki DG. The case for wider use of testing for HIV infection. N Engl J Med. 1989;320:1248-54
22. Lo B, Steinbrook RL, Cooke M, Coates TJ, Walters EJ, Hulley SB. Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms. Ann Intern Med. 1989;110:727-33.
23. Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991;324:954-60.
24. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991;324:961-4.
25. Piatak M Jr, Yang LC, Luk KC, Lifson JD, Saag MS, Clark SJ, et al. Viral dynamics in primary HIV-1 infection [Letter]. Lancet. 1993;341:1099.
26. Kinloch-De Loes S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med. 1995;333:408-13
27. Henrard DR, Phillips J, Windsor I, Fortenberry D, Korte L, Fang C, et al. Detection of human immunodeficiency virus type 1 p24 antigen and plasma RNA: relevance to indeterminate serologic tests. Transfusion. 1994; 34:376-80.
28. Sinicco A, Fora R, Sciandra M, Lucchini A, Caramello P, Gioannini P. Risk of developing AIDS after primary acute HIV-1 infection. J Acquir Immune Defic Syndr. 1993;6:575-81.
29. Keet IP, Krijnen P, Koot M, Lange JM, Miedema F, Goudsmit J, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS. 1993; 7:51-7.
30. Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995;122:573-9.
31. Phair J, Jacobson L, Detels R, Rinaldo C, Saah A, Schrager L, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1992;5:490-6.
32. Seage GR 3d, Mayer KH, Horsburgh CR Jr. Risk of human immunodeficiency virus infection from unprotected receptive anal intercourse increases with decline in immunologic status of infected partners. Am J Epidemiol. 1993;137:899-908.